Study Safety/Efficacy of AmBisome Loading Dose Regimen Versus Standard AmBisome Regimen for Initial Treatment
Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
To evaluate and compare two AmBisome dosing regimens for the initial treatment of invasive
aspergillosis and other filamentous fungal infections diagnosed by modified EORTC criteria in
immunocompromised patients, as determined by overall response rates at end of course of
treatment.